eTheRNA Immunotherapies

eTheRNA Immunotherapies

eTheRNA Immunotherapies

eTheRNA s mission is to help patients to overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system.
Type
B2b
Founded
2013
Raised
$65.1M
Follow us
Alexa global traffic share
Latest funding Show all
€34,000,000
Venture capital (Series B) - 2020
Omega Funds Boehringer Ingelheim Venture Fund Fund+ +7
€1,000,000
Grant - 2017
The Institute for the Promotion of Innovation by Science and Technology in Flanders
Team Size
10+
Employees
Location
Headquarters
€34,000,000 Venture capital (Series B)
FinSMEs

eTheRNA Raises €34M in Series B Financing

€24,000,000 Venture capital (Series A)
biocentury

Immunotherapy play eTheRNA raises EUR 24M

Health